[1]
“Assessment of bacteria exposure in vitro activity to 1st, 2nd, 3rd and 4th generation-cephalosporins and Comparison effects”, Tikrit J. Pharm. Sci., vol. 12, no. 1, pp. 48–55, Apr. 2023, doi: 10.25130/tjphs.2017.12.1.5.48.55.